The Visionary Team

Dr. Branko Stefanovic
Founder & Chief Scientific Officer (CSO)

Dr. Branko Stefanovic, Ph.D., Professor Emeritus, College of Medicine, Florida State University.

Senior member of the National Academy of Inventors.

Founder and CSO of Fibrolex Technologies, LLC.

Over 30 years of experience in research on liver fibrosis and drug discovery.Author of 102 manuscripts with three fibrosis patents granted.

Dr. Adel Nefzi
Co-Investigator

Dr. Adel Nefzi, Ph.D., Associate Professor, College of Medicine, Center for Translational Science, Florida International University.

Directed The Medicinal Chemistry Department, at Torrey Pines Institute for Molecular Studies.

Author of 214 manuscripts with 12 drug patents granted.

"Our vision is a future where liver fibrosis is no longer an incurable disease. We are committed to the ethical development of antifibrotic therapy to improve lives and save lives."